Alterations that enhance autotaxin expression correlate with renal cell carcinoma, breast cancer, ovarian cancer, bladder carcinoma, thyroid carcinoma, and glioblastoma multiforme [37,38,39]. The gene discussed is ENPP2; the disease is glioblastoma.